Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1500 29 33 29 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
mm^3 34 38 34 38 I-lower_bound

Anti 0 4 39 43 B-treatment
- 4 5 43 44 I-treatment
retrovirals 5 16 44 55 I-treatment
: 16 17 55 56 O
delaviridine 18 30 57 69 B-treatment
or 31 33 70 72 O
protease 34 42 73 81 B-treatment
inhibitors 43 53 82 92 I-treatment
( 54 55 93 94 O
ritonavir 55 64 94 103 B-treatment
, 64 65 103 104 O
indinavir 66 75 105 114 B-treatment
, 75 76 114 115 O
lopinavir 77 86 116 125 B-treatment
/ 86 87 125 126 O
ritonavir 87 96 126 135 O
, 96 97 135 136 O
saquinavir 98 108 137 147 B-treatment
, 108 109 147 148 O
nelfinavir 110 120 149 159 B-treatment
) 120 121 159 160 O
or 122 124 161 163 O
cobicistat 125 135 164 174 B-treatment
- 135 136 174 175 I-treatment
boosted 136 143 175 182 I-treatment
antiretrovirals 144 159 183 198 I-treatment

Antibiotics 0 11 199 210 B-treatment
: 11 12 210 211 O
clarithromycin 13 27 212 226 B-treatment
, 27 28 226 227 O
erythromycin 29 41 228 240 B-treatment
, 41 42 240 241 O
telithromycin 43 56 242 255 B-treatment
, 56 57 255 256 O
troleandomycin 58 72 257 271 B-treatment

Antidepressants 0 15 272 287 B-treatment
: 15 16 287 288 O
nefazodone 17 27 289 299 B-treatment

Antidiuretic 0 12 300 312 B-treatment
: 12 13 312 313 O
conivaptan 14 24 314 324 B-treatment

Antifungals 0 11 325 336 B-treatment
: 11 12 336 337 O
itraconzaole 13 25 338 350 B-treatment
, 25 26 350 351 O
ketoconazole 27 39 352 364 B-treatment
, 39 40 364 365 O
voriconazole 41 53 366 378 B-treatment
, 53 54 378 379 O
fluconazole 55 66 380 391 B-treatment
, 66 67 391 392 O
posaconazole 68 80 393 405 B-treatment

Are 0 3 406 409 O
being 4 9 410 415 O
treated 10 17 416 423 O
with 18 22 424 428 O
anticoagulation 23 38 429 444 B-treatment
therapy 39 46 445 452 I-treatment
( 47 48 453 454 O
aspirin 48 55 454 461 B-treatment
and 56 59 462 465 O
nonsteroidal 60 72 466 478 B-treatment
anti 73 77 479 483 I-treatment
- 77 78 483 484 I-treatment
inflammatory 78 90 484 496 I-treatment
drugs 91 96 497 502 I-treatment
[ 97 98 503 504 I-treatment
NSAIDS 98 104 504 510 I-treatment
] 104 105 510 511 I-treatment
are 106 109 512 515 O
allowed 110 117 516 523 O
) 117 118 523 524 O

Aspartate 0 9 525 534 B-clinical_variable
aminotransferase 10 26 535 551 I-clinical_variable
( 27 28 552 553 I-clinical_variable
AST)(serum 28 38 553 563 I-clinical_variable
glutamic 39 47 564 572 I-clinical_variable
oxaloacetic 48 59 573 584 I-clinical_variable
transaminase 60 72 585 597 I-clinical_variable
[ 73 74 598 599 I-clinical_variable
SGOT])/alanine 74 88 599 613 I-clinical_variable
aminotransferase 89 105 614 630 I-clinical_variable
( 106 107 631 632 I-clinical_variable
ALT)(serum 107 117 632 642 I-clinical_variable
glutamate 118 127 643 652 I-clinical_variable
pyruvate 128 136 653 661 I-clinical_variable
transaminase 137 149 662 674 I-clinical_variable
[ 150 151 675 676 I-clinical_variable
SGPT 151 155 676 680 I-clinical_variable
] 155 156 680 681 I-clinical_variable
) 156 157 681 682 O
= 158 159 683 684 O
< 159 160 684 685 O
2.5 161 164 686 689 B-upper_bound
x 165 166 690 691 I-upper_bound
ULN 167 170 692 695 I-upper_bound

Creatinine 0 10 696 706 B-clinical_variable
= 11 12 707 708 O
< 12 13 708 709 O
1.6 14 17 710 713 O
mg 18 20 714 716 O
/ 20 21 716 717 O
dl 21 23 717 719 O
( 24 25 720 721 O
for 25 28 721 724 O
patients 29 37 725 733 O
with 38 42 734 738 O
> 43 44 739 740 O
1.6 45 48 741 744 O
mg 49 51 745 747 O
/ 51 52 747 748 O
dl 52 54 748 750 O
, 54 55 750 751 O
calculated 56 66 752 762 B-clinical_variable
or 67 69 763 765 I-clinical_variable
measured 70 78 766 774 I-clinical_variable
creatinine 79 89 775 785 I-clinical_variable
clearance 90 99 786 795 I-clinical_variable
must 100 104 796 800 O
be 105 107 801 803 O
> 108 109 804 805 O
= 109 110 805 806 O
55 111 113 807 809 B-lower_bound
mL 114 116 810 812 I-lower_bound
/ 116 117 812 813 I-lower_bound
minute 117 123 813 819 I-lower_bound
[ 124 125 820 821 O
Cockcroft 125 134 821 830 O
- 134 135 830 831 O
Gault 135 140 831 836 O
] 140 141 836 837 O
) 141 142 837 838 O

Gastrointestinal 0 16 839 855 B-chronic_disease
( 17 18 856 857 I-chronic_disease
GI 18 20 857 859 I-chronic_disease
): 20 22 859 861 I-chronic_disease
cimetidine 23 33 862 872 B-treatment
, 33 34 872 873 O
aprepitant 35 45 874 884 B-treatment

Has 0 3 885 888 O
glucose-6 4 13 889 898 B-chronic_disease
- 13 14 898 899 I-chronic_disease
phosphate 14 23 899 908 I-chronic_disease
dehydrogenase 24 37 909 922 I-chronic_disease
( 38 39 923 924 I-chronic_disease
G6PD 39 43 924 928 I-chronic_disease
) 43 44 928 929 I-chronic_disease
deficiency 45 55 930 940 I-chronic_disease

Has 0 3 941 944 O
history 4 11 945 952 O
of 12 14 953 955 O
calcium 15 22 956 963 B-chronic_disease
oxalate 23 30 964 971 I-chronic_disease
stones 31 37 972 978 I-chronic_disease

Has 0 3 979 982 O
history 4 11 983 990 O
of 12 14 991 993 O
iron 15 19 994 998 B-chronic_disease
overload 20 28 999 1007 I-chronic_disease

Have 0 4 1008 1012 O
ECOG 5 9 1013 1017 B-clinical_variable
performance 10 21 1018 1029 I-clinical_variable
status 22 28 1030 1036 I-clinical_variable
0 29 30 1037 1038 B-lower_bound
- 30 31 1038 1039 O
1 31 32 1039 1040 B-upper_bound

Have 0 4 1041 1045 O
a 5 6 1046 1047 O
known 7 12 1048 1053 O
history 13 20 1054 1061 O
of 21 23 1062 1064 O
human 24 29 1065 1070 B-chronic_disease
immunodeficiency 30 46 1071 1087 I-chronic_disease
virus 47 52 1088 1093 I-chronic_disease
( 53 54 1094 1095 I-chronic_disease
HIV 54 57 1095 1098 I-chronic_disease
) 57 58 1098 1099 I-chronic_disease
( 59 60 1100 1101 O
HIV 60 63 1101 1104 O
1/2 64 67 1105 1108 O
antibodies 68 78 1109 1119 O
) 78 79 1119 1120 O
, 79 80 1120 1121 O
hepatitis 81 90 1122 1131 B-chronic_disease
B 91 92 1132 1133 I-chronic_disease
, 92 93 1133 1134 O
or 94 96 1135 1137 O
hepatitis 97 106 1138 1147 B-chronic_disease
C 107 108 1148 1149 I-chronic_disease
infection 109 118 1150 1159 I-chronic_disease

Have 0 4 1160 1164 O
a 5 6 1165 1166 O
pathological 7 19 1167 1179 O
diagnosis 20 29 1180 1189 O
of 30 32 1190 1192 O
prostate 33 41 1193 1201 B-cancer
carcinoma 42 51 1202 1211 I-cancer

Have 0 4 1212 1216 O
an 5 7 1217 1219 O
estimated 8 17 1220 1229 O
life 18 22 1230 1234 B-clinical_variable
expectancy 23 33 1235 1245 I-clinical_variable
> 34 35 1246 1247 O
4 36 37 1248 1249 B-lower_bound
months 38 44 1250 1256 I-lower_bound

Have 0 4 1257 1261 O
end 5 8 1262 1265 B-chronic_disease
stage 9 14 1266 1271 I-chronic_disease
renal 15 20 1272 1277 I-chronic_disease
disease 21 28 1278 1285 I-chronic_disease

Have 0 4 1286 1290 O
evaluable 5 14 1291 1300 O
disease 15 22 1301 1308 O
by 23 25 1309 1311 O
Response 26 34 1312 1320 O
Evaluation 35 45 1321 1331 O
Criteria 46 54 1332 1340 O
in 55 57 1341 1343 O
Solid 58 63 1344 1349 O
Tumors 64 70 1350 1356 O
( 71 72 1357 1358 O
RECIST 72 78 1358 1364 O
) 78 79 1364 1365 O
1.1 80 83 1366 1369 O
and/or 84 90 1370 1376 O
Prostate 91 99 1377 1385 B-cancer
Cancer 100 106 1386 1392 I-cancer
Working 107 114 1393 1400 O
Group 115 120 1401 1406 O
2 121 122 1407 1408 O
( 123 124 1409 1410 O
PCWG2 124 129 1410 1415 O
) 129 130 1415 1416 O
criteria 131 139 1417 1425 O

Have 0 4 1426 1430 O
had 5 8 1431 1434 O
had 9 12 1435 1438 O
surgery 13 20 1439 1446 B-treatment
within 21 27 1447 1453 O
four 28 32 1454 1458 B-upper_bound
weeks 33 38 1459 1464 I-upper_bound
of 39 41 1465 1467 O
dosing 42 48 1468 1474 O
of 49 51 1475 1477 O
investigational 52 67 1478 1493 B-treatment
agent 68 73 1494 1499 I-treatment
, 73 74 1499 1500 O
excluding 75 84 1501 1510 O
minor 85 90 1511 1516 B-treatment
procedures 91 101 1517 1527 I-treatment
( 102 103 1528 1529 O
dental 103 109 1529 1535 B-treatment
work 110 114 1536 1540 I-treatment
, 114 115 1540 1541 O
skin 116 120 1542 1546 B-treatment
biopsy 121 127 1547 1553 I-treatment
, 127 128 1553 1554 O
etc 129 132 1555 1558 O
. 132 133 1558 1559 O
) 133 134 1559 1560 O
, 134 135 1560 1561 O
celiac 136 142 1562 1568 B-treatment
plexus 143 149 1569 1575 I-treatment
block 150 155 1576 1581 I-treatment
, 155 156 1581 1582 O
and 157 160 1583 1586 O
biliary 161 168 1587 1594 B-treatment
stent 169 174 1595 1600 I-treatment
placement 175 184 1601 1610 I-treatment

Have 0 4 1611 1615 O
had 5 8 1616 1619 O
known 9 14 1620 1625 O
active 15 21 1626 1632 O
central 22 29 1633 1640 B-cancer
nervous 30 37 1641 1648 I-cancer
system 38 44 1649 1655 I-cancer
( 45 46 1656 1657 I-cancer
CNS 46 49 1657 1660 I-cancer
) 49 50 1660 1661 I-cancer
metastases 51 61 1662 1672 I-cancer
and/or 62 68 1673 1679 O
carcinomatous 69 82 1680 1693 B-cancer
meningitis 83 93 1694 1704 I-cancer
; 93 94 1704 1705 O
subjects 95 103 1706 1714 O
with 104 108 1715 1719 O
previously 109 119 1720 1730 O
treated 120 127 1731 1738 O
brain 128 133 1739 1744 B-cancer
metastases 134 144 1745 1755 I-cancer
may 145 148 1756 1759 O
participate 149 160 1760 1771 O
provided 161 169 1772 1780 O
they 170 174 1781 1785 O
are 175 178 1786 1789 O
stable 179 185 1790 1796 O
( 186 187 1797 1798 O
without 187 194 1798 1805 O
evidence 195 203 1806 1814 O
of 204 206 1815 1817 O
progression 207 218 1818 1829 O
by 219 221 1830 1832 O
imaging 222 229 1833 1840 B-treatment
for 230 233 1841 1844 O
at 234 236 1845 1847 O
least 237 242 1848 1853 O
four 243 247 1854 1858 B-lower_bound
weeks 248 253 1859 1864 I-lower_bound
prior 254 259 1865 1870 I-lower_bound
to 260 262 1871 1873 O
the 263 266 1874 1877 O
first 267 272 1878 1883 O
dose 273 277 1884 1888 O
of 278 280 1889 1891 O
trial 281 286 1892 1897 B-treatment
treatment 287 296 1898 1907 I-treatment
and 297 300 1908 1911 O
any 301 304 1912 1915 O
neurologic 305 315 1916 1926 O
symptoms 316 324 1927 1935 O
have 325 329 1936 1940 O
returned 330 338 1941 1949 O
to 339 341 1950 1952 O
baseline 342 350 1953 1961 O
) 350 351 1961 1962 O
, 351 352 1962 1963 O
have 353 357 1964 1968 O
no 358 360 1969 1971 O
evidence 361 369 1972 1980 O
of 370 372 1981 1983 O
new 373 376 1984 1987 O
or 377 379 1988 1990 O
enlarging 380 389 1991 2000 O
brain 390 395 2001 2006 O
metastases 396 406 2007 2017 O
, 406 407 2017 2018 O
and 408 411 2019 2022 O
are 412 415 2023 2026 O
not 416 419 2027 2030 O
using 420 425 2031 2036 O
steroids 426 434 2037 2045 B-treatment
for 435 438 2046 2049 O
CNS 439 442 2050 2053 O
involvement 443 454 2054 2065 O
for 455 458 2066 2069 O
at 459 461 2070 2072 O
least 462 467 2073 2078 O
one 468 471 2079 2082 B-lower_bound
week 472 476 2083 2087 I-lower_bound
prior 477 482 2088 2093 I-lower_bound
to 483 485 2094 2096 O
trial 486 491 2097 2102 O
treatment 492 501 2103 2112 O
; 501 502 2112 2113 O
patients 503 511 2114 2122 O
with 512 516 2123 2127 O
primary 517 524 2128 2135 B-cancer
brain 525 530 2136 2141 I-cancer
tumors 531 537 2142 2148 I-cancer
are 538 541 2149 2152 O
not 542 545 2153 2156 O
eligible 546 554 2157 2165 O
; 554 555 2165 2166 O
however 556 563 2167 2174 O
, 563 564 2174 2175 O
as 565 567 2176 2178 O
patients 568 576 2179 2187 O
are 577 580 2188 2191 O
completing 581 591 2192 2202 O
abiraterone 592 603 2203 2214 B-treatment
therapy 604 611 2215 2222 I-treatment
, 611 612 2222 2223 O
they 613 617 2224 2228 O
will 618 622 2229 2233 O
be 623 625 2234 2236 O
allowed 626 633 2237 2244 O
to 634 636 2245 2247 O
continue 637 645 2248 2256 O
up 646 648 2257 2259 O
to 649 651 2260 2262 O
10 652 654 2263 2265 B-upper_bound
mg 655 657 2266 2268 I-upper_bound
/ 657 658 2268 2269 I-upper_bound
day 658 661 2269 2272 I-upper_bound
of 662 664 2273 2275 O
prednisone 665 675 2276 2286 B-treatment

Have 0 4 2287 2291 O
had 5 8 2292 2295 O
palliative 9 19 2296 2306 B-treatment
radiation 20 29 2307 2316 I-treatment
or 30 32 2317 2319 O
biological 33 43 2320 2330 B-treatment
cancer 44 50 2331 2337 I-treatment
therapy 51 58 2338 2345 I-treatment
within 59 65 2346 2352 O
2 66 67 2353 2354 B-upper_bound
weeks 68 73 2355 2360 I-upper_bound
prior 74 79 2361 2366 I-upper_bound
to 80 82 2367 2369 O
the 83 86 2370 2373 O
first 87 92 2374 2379 O
dose 93 97 2380 2384 O
of 98 100 2385 2387 O
study 101 106 2388 2393 B-treatment
drug 107 111 2394 2398 I-treatment

Have 0 4 2399 2403 O
had 5 8 2404 2407 O
prior 9 14 2408 2413 B-treatment
chemotherapy 15 27 2414 2426 I-treatment
for 28 31 2427 2430 O
metastatic 32 42 2431 2441 B-cancer
disease 43 50 2442 2449 I-cancer
in 51 53 2450 2452 O
castration 54 64 2453 2463 B-cancer
- 64 65 2463 2464 I-cancer
resistant 65 74 2464 2473 I-cancer
prostate 75 83 2474 2482 I-cancer
cancer 84 90 2483 2489 I-cancer
( 91 92 2490 2491 O
prior 92 97 2491 2496 O
chemotherapy 98 110 2497 2509 O
for 111 114 2510 2513 O
hormone 115 122 2514 2521 B-cancer
- 122 123 2521 2522 I-cancer
sensitive 123 132 2522 2531 I-cancer
disease 133 140 2532 2539 I-cancer
, 140 141 2539 2540 O
more 142 146 2541 2545 O
than 147 151 2546 2550 O
twelve 152 158 2551 2557 B-lower_bound
months 159 165 2558 2564 I-lower_bound
prior 166 171 2565 2570 I-lower_bound
to 172 174 2571 2573 O
registration 175 187 2574 2586 O
, 187 188 2586 2587 O
is 189 191 2588 2590 O
acceptable 192 202 2591 2601 O
) 202 203 2601 2602 O

Have 0 4 2603 2607 O
metastatic 5 15 2608 2618 O
castration 16 26 2619 2629 O
- 26 27 2629 2630 O
resistant 27 36 2630 2639 O
prostate 37 45 2640 2648 B-cancer
cancer 46 52 2649 2655 I-cancer
( 53 54 2656 2657 O
prostate 54 62 2657 2665 O
cancer 63 69 2666 2672 O
progressing 70 81 2673 2684 O
despite 82 89 2685 2692 O
castrate 90 98 2693 2701 B-clinical_variable
levels 99 105 2702 2708 I-clinical_variable
of 106 108 2709 2711 I-clinical_variable
testosterone 109 121 2712 2724 I-clinical_variable
[ 122 123 2725 2726 O
< 123 124 2726 2727 O
50 125 127 2728 2730 B-upper_bound
ng 128 130 2731 2733 I-upper_bound
/ 130 131 2733 2734 I-upper_bound
dL 131 133 2734 2736 I-upper_bound
] 133 134 2736 2737 O
using 135 140 2738 2743 O
standard 141 149 2744 2752 O
measures 150 158 2753 2761 O
of 159 161 2762 2764 O
progression 162 173 2765 2776 O
defined 174 181 2777 2784 O
by 182 184 2785 2787 O
Prostate 185 193 2788 2796 B-cancer
Cancer 194 200 2797 2803 I-cancer
Working 201 208 2804 2811 O
Group 209 214 2812 2817 O
2 215 216 2818 2819 O
) 216 217 2819 2820 O
, 217 218 2820 2821 O
are 219 222 2822 2825 O
chemo 223 228 2826 2831 O
- 228 229 2831 2832 O
naÃ¯ve 229 234 2832 2837 O
for 235 238 2838 2841 O
metastatic 239 249 2842 2852 O
castration 250 260 2853 2863 O
- 260 261 2863 2864 O
resistant 261 270 2864 2873 O
prostate 271 279 2874 2882 O
cancer 280 286 2883 2889 O
( 287 288 2890 2891 O
mCRPC 288 293 2891 2896 O
) 293 294 2896 2897 O
; 294 295 2897 2898 O
patients 296 304 2899 2907 O
must 305 309 2908 2912 O
have 310 314 2913 2917 O
symptomatic 315 326 2918 2929 O
disease 327 334 2930 2937 O
or 335 337 2938 2940 O
visceral 338 346 2941 2949 B-cancer
metastases 347 357 2950 2960 I-cancer
or 358 360 2961 2963 O
otherwise 361 370 2964 2973 O
be 371 373 2974 2976 O
eligible 374 382 2977 2985 O
for 383 386 2986 2989 O
docetaxel 387 396 2990 2999 B-treatment
treatment 397 406 3000 3009 I-treatment
per 407 410 3010 3013 O
investigator 411 423 3014 3026 O
judgment 424 432 3027 3035 O
( 433 434 3036 3037 O
e.g. 434 438 3037 3041 O
for 439 442 3042 3045 O
progression 443 454 3046 3057 O
on 455 457 3058 3060 O
imaging 458 465 3061 3068 O
or 466 468 3069 3071 O
rapidly 469 476 3072 3079 O
rising 477 483 3080 3086 O
PSA 484 487 3087 3090 O
despite 488 495 3091 3098 O
2nd 496 499 3099 3102 O
line 500 504 3103 3107 O
hormonal 505 513 3108 3116 B-treatment
treatment 514 523 3117 3126 I-treatment
) 523 524 3126 3127 O

Have 0 4 3128 3132 O
received 5 13 3133 3141 O
other 14 19 3142 3147 O
investigational 20 35 3148 3163 B-treatment
drugs 36 41 3164 3169 I-treatment
within 42 48 3170 3176 O
28 49 51 3177 3179 B-upper_bound
days 52 56 3180 3184 I-upper_bound
prior 57 62 3185 3190 I-upper_bound
to 63 65 3191 3193 O
enrollment 66 76 3194 3204 O

Have 0 4 3205 3209 O
uncontrolled 5 17 3210 3222 O
intercurrent 18 30 3223 3235 O
illness 31 38 3236 3243 O
, 38 39 3243 3244 O
including 40 49 3245 3254 O
but 50 53 3255 3258 O
not 54 57 3259 3262 O
limited 58 65 3263 3270 O
to 66 68 3271 3273 O
ongoing 69 76 3274 3281 O
or 77 79 3282 3284 O
active 80 86 3285 3291 B-chronic_disease
infection 87 96 3292 3301 I-chronic_disease
, 96 97 3301 3302 O
symptomatic 98 109 3303 3314 O
congestive 110 120 3315 3325 B-chronic_disease
heart 121 126 3326 3331 I-chronic_disease
failure 127 134 3332 3339 I-chronic_disease
, 134 135 3339 3340 O
unstable 136 144 3341 3349 B-chronic_disease
angina 145 151 3350 3356 I-chronic_disease
pectoris 152 160 3357 3365 I-chronic_disease
, 160 161 3365 3366 O
cardiac 162 169 3367 3374 B-chronic_disease
arrhythmia 170 180 3375 3385 I-chronic_disease
, 180 181 3385 3386 O
or 182 184 3387 3389 O
psychiatric 185 196 3390 3401 B-chronic_disease
illness 197 204 3402 3409 I-chronic_disease
/ 204 205 3409 3410 I-chronic_disease
social 205 211 3410 3416 I-chronic_disease
situations 212 222 3417 3427 I-chronic_disease
that 223 227 3428 3432 O
would 228 233 3433 3438 O
limit 234 239 3439 3444 O
compliance 240 250 3445 3455 O
with 251 255 3456 3460 O
study 256 261 3461 3466 O
requirements 262 274 3467 3479 O

Hemoglobin 0 10 3480 3490 B-clinical_variable
> 11 12 3491 3492 O
= 12 13 3492 3493 O
9 14 15 3494 3495 B-lower_bound
g 16 17 3496 3497 I-lower_bound
/ 17 18 3497 3498 I-lower_bound
dL 18 20 3498 3500 I-lower_bound

Hepatitis 0 9 3501 3510 B-chronic_disease
C 10 11 3511 3512 I-chronic_disease
: 11 12 3512 3513 O
boceprevir 13 23 3514 3524 B-treatment
, 23 24 3524 3525 O
telaprevir 25 35 3526 3536 B-treatment

Is 0 2 3537 3539 O
expected 3 11 3540 3548 O
to 12 14 3549 3551 O
require 15 22 3552 3559 O
any 23 26 3560 3563 O
other 27 32 3564 3569 O
form 33 37 3570 3574 O
of 38 40 3575 3577 O
systemic 41 49 3578 3586 B-treatment
or 50 52 3587 3589 O
localized 53 62 3590 3599 B-treatment
antineoplastic 63 77 3600 3614 I-treatment
therapy 78 85 3615 3622 I-treatment
while 86 91 3623 3628 O
on 92 94 3629 3631 O
study 95 100 3632 3637 O

Men 0 3 3638 3641 B-gender
of 4 6 3642 3644 O
reproductive 7 19 3645 3657 O
potential 20 29 3658 3667 O
and 30 33 3668 3671 O
those 34 39 3672 3677 O
who 40 43 3678 3681 O
are 44 47 3682 3685 O
surgically 48 58 3686 3696 B-treatment
sterilized 59 69 3697 3707 I-treatment
( 70 71 3708 3709 O
i.e. 71 75 3709 3713 O
, 75 76 3713 3714 O
postvasectomy 77 90 3715 3728 B-treatment
) 90 91 3728 3729 O
must 92 96 3730 3734 O
agree 97 102 3735 3740 B-contraception_consent
to 103 105 3741 3743 I-contraception_consent
practice 106 114 3744 3752 I-contraception_consent
effective 115 124 3753 3762 I-contraception_consent
barrier 125 132 3763 3770 I-contraception_consent
contraception 133 146 3771 3784 I-contraception_consent
that 147 151 3785 3789 O
has 152 155 3790 3793 O
an 156 158 3794 3796 O
expected 159 167 3797 3805 B-clinical_variable
failure 168 175 3806 3813 I-clinical_variable
rate 176 180 3814 3818 I-clinical_variable
of 181 183 3819 3821 O
< 184 185 3822 3823 O
1 186 187 3824 3825 B-upper_bound
% 187 188 3825 3826 I-upper_bound
during 189 195 3827 3833 O
and 196 199 3834 3837 O
for 200 203 3838 3841 O
30 204 206 3842 3844 B-upper_bound
days 207 211 3845 3849 I-upper_bound
after 212 217 3850 3855 I-upper_bound
discontinuation 218 233 3856 3871 O
of 234 236 3872 3874 O
study 237 242 3875 3880 B-treatment
treatment 243 252 3881 3890 I-treatment

Patient 0 7 3891 3898 O
may 8 11 3899 3902 O
be 12 14 3903 3905 O
receiving 15 24 3906 3915 O
bone 25 29 3916 3920 B-treatment
targeted 30 38 3921 3929 I-treatment
agents 39 45 3930 3936 I-treatment

Patients 0 8 3937 3945 O
may 9 12 3946 3949 O
be 13 15 3950 3952 O
receiving 16 25 3953 3962 O
continuous 26 36 3963 3973 B-treatment
hormonal 37 45 3974 3982 I-treatment
ablation 46 54 3983 3991 I-treatment
with 55 59 3992 3996 I-treatment
surgical 60 68 3997 4005 I-treatment
or 69 71 4006 4008 I-treatment
medical 72 79 4009 4016 I-treatment
castration 80 90 4017 4027 I-treatment
with 91 95 4028 4032 O
baseline 96 104 4033 4041 O
testosterone 105 117 4042 4054 B-clinical_variable
< 118 119 4055 4056 O
50 120 122 4057 4059 B-upper_bound
ng 123 125 4060 4062 I-upper_bound
/ 125 126 4062 4063 I-upper_bound
dL 126 128 4063 4065 I-upper_bound

Patients 0 8 4066 4074 O
who 9 12 4075 4078 O
require 13 20 4079 4086 O
frequent 21 29 4087 4095 O
( 30 31 4096 4097 O
several 31 38 4097 4104 O
times 39 44 4105 4110 O
a 45 46 4111 4112 O
day 47 50 4113 4116 O
) 50 51 4116 4117 O
monitoring 52 62 4118 4128 O
of 63 65 4129 4131 O
their 66 71 4132 4137 O
blood 72 77 4138 4143 O
glucose 78 85 4144 4151 O
or 86 88 4152 4154 O
patients 89 97 4155 4163 O
who 98 101 4164 4167 O
have 102 106 4168 4172 O
recently 107 115 4173 4181 O
been 116 120 4182 4186 O
hospitalized 121 133 4187 4199 B-treatment
for 134 137 4200 4203 O
glucose 138 145 4204 4211 O
control 146 153 4212 4219 O

Platelets 0 9 4220 4229 B-clinical_variable
> 10 11 4230 4231 O
= 11 12 4231 4232 O
100,000 13 20 4233 4240 B-lower_bound
/ 20 21 4240 4241 I-lower_bound
mm^3 21 25 4241 4245 I-lower_bound

Total 0 5 4246 4251 B-clinical_variable
bilirubin 6 15 4252 4261 I-clinical_variable
= 16 17 4262 4263 O
< 17 18 4263 4264 O
1.0 19 22 4265 4268 B-upper_bound
upper 23 28 4269 4274 I-upper_bound
limit 29 34 4275 4280 I-upper_bound
of 35 37 4281 4283 I-upper_bound
normal 38 44 4284 4290 I-upper_bound
( 45 46 4291 4292 I-upper_bound
ULN 46 49 4292 4295 I-upper_bound
) 49 50 4295 4296 I-upper_bound

